Drug Database
Back to search

United States· US:70518-2023_499b1561-882b-8553-e063-6294a90ad423

SOLU-MEDROL

A medicinal product containing methylprednisolone sodium succinate, registered in United States by REMEDYREPACK INC..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedSOLU-MEDROLATC—REGISTER NO.US:70518-2023_499b156…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about methylprednisolone sodium succinateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHYLPREDNISOLONE SODIUM SUCCINATE
Manufacturer
REMEDYREPACK INC.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    7051820231
    25 VIAL in 1 CARTON (70518-2023-1) / 2 mL in 1 VIAL (70518-2023-0)
  • ndc11
    70518-2023-1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Methylprednisolone sodium succinate in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylprednisolone sodium succinate products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Solu-Medrol
  • Bulgaria · Метилпреднизолон Чайкафарма
  • Czechia · Solu-Medrol
  • Germany · Methylprednisolon Hikma, Metypred
  • Spain · Urbason
  • France · Methylprednisolone Hikma
  • United Kingdom (Northern Ireland) · Methylprednisolone Hikma Farmacêutica (Portugal), Methylprednisolone Pfizer
  • Hungary · Metilprednizolon Teva
  • Italy · Cortrium, Lisamethyle
  • Poland · Meprelon
  • Portugal · Metilprednisolona Hikma
  • Slovakia · Metylprednizolón Hikma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f0e0b1f1-162d-44ca-850d-cfecef3ce55f
GET /v1/drugs/f0e0b1f1-162d-44ca-850d-cfecef3ce55f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "source": "ndc",
  "strength": "125",
  "substance": "METHYLPREDNISOLONE SODIUM SUCCINATE",
  "productndc": "70518-2023",
  "dosage_form": "INJECTION, POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/2mL",
  "application_number": "NDA011856",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about methylprednisolone sodium succinate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console